Innovative Method for Identifying and Re-Engaging Lost HIV Clinic Patients: The Navigation Program
Description: Eligible lost clinic patients included HIV-infected adults with either: a) no reported VL/CD4 measures in previous 12mo per HIV surveillance; b) no reported VL/CD4 in 7-12mo and most recent VL>200copies/ml; c) newly- diagnosed and not linked to care within 3mo; and d) recent incarceration with no regular provider.
Lessons Learned: Navigation Program pilot data for 499 lost clinic patients at four HIV clinics has determined that 43% were ineligible(in-care elsewhere, deceased, not LAC residents); 43% were unavailable or had invalid contact information and 12% were located and enrolled(n=47). The majority were Latino(68%), male(72%), and uninsured(51%).The most useful contact information came from HIV surveillance(39%) and clinic medical records(36%). An average of 7 appointments over 90 days was needed to link patients to care. A total of 98% of participants were linked to care.
Recommendations: HIV surveillance and clinic medical records provided the most useful contact information and the modified ARTAS intervention was effective at linking persons to care.
Learning Areas:Planning of health education strategies, interventions, and programs
Public health or related research
Evaluate the effectiveness of using multiple surveillance sources for identifying HIV infected persons who have fallen out of care. Compare different intervention strategies designed to re-engage HIV infected person who have fallen out of care.
Keyword(s): HIV/AIDS, HIV Interventions
Qualified on the content I am responsible for because: I have multiple years of experience in the fields of HIV research and program evaluation. I have also performed program management for multiple federally funded research projects related to HIV prevention and health care delivery.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.